Boosting One Brain Protein in Astrocytes Slows Aging Throughout the Mouse Body
Raising FGF13 in brain astrocytes improved memory and cut inflammation and senescence in organs far from the brain in aging mice.
Summary
Brain support cells called astrocytes may help set the pace of aging for the whole body. Researchers reported in Aging Cell that levels of fibroblast growth factor 13 (FGF13) fall in aging astrocytes. When they removed FGF13 from astrocytes in older mice, memory got worse, and signs of cellular aging rose in the skin, liver, spleen, kidney, and heart. Blood levels of inflammatory molecules also climbed. When they raised FGF13 in astrocytes of old mice, the animals performed on memory tests much like young mice, showed lower inflammatory signals in the blood, had less senescence in several organs, and gained less weight with age. In dish experiments, FGF13-deficient astrocytes harmed neuron connections and pushed immune cells called microglia toward inflammation, and restoring FGF13 reversed much of this. The findings suggest the brain can broadcast aging signals to the body, though all of this work was done in mice.
Detailed Summary
Most aging research treats the brain as a victim of aging. This study asks whether the brain might also be a driver. Researchers focused on astrocytes, star-shaped support cells that maintain neurons and regulate inflammation, and on a protein called fibroblast growth factor 13 (FGF13), whose role in aging had not been well explored.
Using public datasets, the team found that FGF13 declines with age in mouse brain cells other than neurons, including astrocytes, oligodendrocytes, and microglia. Macaque data pointed the same way, with a strong effect in astrocytes. Deleting FGF13 in astrocytes of aging mice worsened performance on the Morris water maze, increased senescent cells in the heart, skin, liver, spleen, and kidney, and raised circulating inflammatory cytokines. The authors concluded that the brain was amplifying and transmitting aging signals through the blood.
The reverse experiment gave encouraging results. Increasing FGF13 in astrocytes of older mice brought water maze performance close to that of young mice and improved results on the elevated plus maze and open field tests, though not to young levels. Blood IFN-γ and IL-6 fell substantially. Senescence dropped modestly in skin, liver, spleen, and kidney, but not in the heart. The treated mice also gained less age-related weight.
Cell experiments offered mechanistic clues. FGF13-deficient astrocytes showed higher complement C3 and Cx43, markers linked to neurodegeneration and neuronal injury. They damaged neuronal synapses and prompted microglia to release inflammatory factors. Raising FGF13 restored synaptic proteins, lowered microglial cytokines, and reduced injury-associated proteins. RNA sequencing showed hundreds of genes changed, and the article hints that autophagy may be central.
For readers, this is a mechanism story, not a protocol. No supplement or drug raises astrocytic FGF13 in humans. The work does reinforce that controlling brain inflammation may influence whole-body aging. Caveats are significant: the data come from mice, most body-wide effects were modest, the heart showed no benefit, and the intervention required genetic targeting. Human relevance, safety, and durability remain unknown.
Key Findings
- FGF13 declines with age in mouse and macaque brain cells, notably astrocytes, but not in neurons.
- Deleting astrocytic FGF13 worsened memory and increased senescence in heart, skin, liver, spleen, and kidney.
- Raising astrocytic FGF13 in old mice brought spatial memory near young levels and lowered blood IL-6 and IFN-γ.
- FGF13-deficient astrocytes raised C3 and Cx43, harmed neuronal synapses, and drove microglial inflammation in culture.
- Overexpression also reduced age-related weight gain, but body-wide senescence benefits were modest and absent in the heart.
Methodology
This is a news-style research summary from Lifespan.io of a peer-reviewed mouse study in Aging Cell. The evidence combines public transcriptomic datasets, astrocyte-specific knockout and overexpression in mice, behavioral tests, and cell co-culture experiments. Lifespan.io is a generally reliable longevity news outlet, but this excerpt is truncated.
Study Limitations
All findings are from mice and cell cultures, and many body-wide effects were modest, so human translation is uncertain. The article text is cut off before fully describing the autophagy mechanism, and the study did not appear to test lifespan. Verify details, effect sizes, and statistics in the original Aging Cell paper.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: